![]() | |
Clinical data | |
---|---|
Other names | Methphendrazine; HM-11; MO-482;N-Aminomethamphetamine; Methamphetamine hydrazide;N-Amino-N-methylamphetamine |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C10H16N2 |
Molar mass | 164.252 g·mol−1 |
Metfendrazine (developmental code namesHM-11,MO-482), also known asmethphendrazine, is anirreversible andnonselectivemonoamine oxidase inhibitor (MAOI) of thehydrazine family.[1][2] It was investigated as anantidepressant, but was never marketed.
Metfendrazine, also known as methamphetamine hydrazide, is aphenethylamine,amphetamine, andhydrazinederivative.
It is ananalogue and derivative ofphenelzine (phenethylamine hydrazide) andpheniprazine (amphetamine hydrazide), as well as ofphenethylamine,amphetamine, andmethamphetamine.